This research investigated whether AI-guided handheld ultrasound can help diagnose deep vein thrombosis (DVT) in primary care. Through a systematic review, a clinical study involving 565 patients, and stakeholder interviews, the research found promising results but highlighted challenges involving image quality, accountability, and integration into NHS healthcare systems.

This research develops a physics-based method for measuring lung elasticity from medical imaging to predict which emphysema patients will benefit from lung valve treatment. By creating detailed elasticity maps, the work aims to improve treatment selection, enhance patient outcomes, and provide new quantitative tools for assessing lung health.

This research develops nanobubble-enhanced ultrasound imaging as an accessible alternative to MRI for cancer diagnosis. Tiny gas-filled nanoparticles amplify ultrasound signals and improve image quality, particularly in prostate cancer. The technology could reduce diagnostic delays, lower costs, and provide high-quality medical imaging to more patients worldwide.

This research examines how physicians' imaging-ordering strategies affect emergency department efficiency. Using electronic health records and an instrumental variable approach based on random physician assignment, the study finds that discretionary batching of imaging tests increases length of stay by 65% and doubles imaging utilization, ultimately reducing patient flow and safety.

This 3MT® presentation describes how artificial intelligence can help non-specialist clinicians diagnose deep vein thrombosis using AI-guided handheld ultrasound devices. By enabling faster point-of-care diagnosis in GP surgeries, the project aims to reduce hospital referrals, improve accessibility for vulnerable patients, and help healthcare systems manage increasing clinical demand more efficiently.

This research develops engineered ultrasonic reporters that allow ultrasound imaging to detect molecular activity rather than only anatomical structure. By targeting biological signals associated with cancer progression and cellular communication, the work aims to distinguish aggressive disease earlier and improve precision medicine through real-time, noninvasive monitoring of underlying cellular behavior.

This research uses artificial intelligence to predict the progression of Alzheimer’s disease and cancer using medical imaging data. By analyzing brain scans, tumor scans, and treatment responses, AI models can forecast disease development and treatment outcomes, enabling earlier intervention, more personalized care, and improved quality of life for aging populations.

This research improves photoacoustic imaging, a technique that uses light-generated sound waves to visualize tissue oxygenation deep inside the body. By calibrating measurements using highly oxygenated arterial blood, the method overcomes longstanding accuracy limitations and avoids skin-tone bias, potentially improving early tumor detection and non-invasive monitoring of tissue health.

This research explores asthma by recreating lung airways using 3D bioprinting. By simulating low-oxygen conditions and imaging structural changes, it investigates how exaggerated immune responses narrow airways. These models enable detailed study of disease mechanisms and offer a platform to develop treatments, ultimately advancing efforts toward preventing or curing asthma.

This research explores quantum radar signal processing, using quantum entanglement to improve detection by better separating signal from noise. It demonstrates that quantum radars are experimentally viable and mathematically comparable to conventional systems, with potential advantages. Applications include low-power, safe technologies such as medical imaging and interference-free sensing.